While the supporting role of families and friends has been widely recognized in cancer care, little data exist on how they influence patients’ decisions regarding clinical trial participation, accounting for patients’ decisional preferences. The goal of our study was to examine the process of clinical trial decision-making from the perspective of adults with cancer and their decision partners. Semi-structured interviews were conducted with 12 patients and 12 decision partners—family and friends engaged in the medical decision-making. Themes included: (1) having the ability and confidence to make decisions; (2) gaining insight about clinical trials; (3) trusting someone in the process; and (4) realizing readiness and context. Our findings will enhance understanding of how patients make clinical trial decisions based on decisional preferences from the perspectives of patients and decision partners. The findings may also help to increase clinician awareness and inclusion of decision partners in conversations regarding clinical trials.
AsieduG. B.RidgewayJ. L.CarrollK.JatoiA.Radecki BreitkopfC. (2018). “Ultimately, mom has the call”: Viewing clinical trial decision making among patients with ovarian cancer through the lens of relational autonomy. Health Expectations, 21(6), 981–989. https://doi.org/10.1111/hex.12691
2.
BarakatL. P.SchwartzL. A.ReillyA.DeatrickJ. A.BalisF. (2014). A qualitative study of phase III cancer clinical trial enrollment decision-making: Perspectives from adolescents, young adults, caregivers, and providers. Journal of Adolescent and Young Adult Oncology, 3(1), 3–11. https://doi.org/10.1089/jayao.2013.0011
3.
BascheM.BarónA. E.EckhardtS. G.BalducciL.PerskyM.LevinA.JacksonN.ZengC.VranasP.SteinerJ. F. (2008). Barriers to enrollment of elderly adults in early-phase cancer clinical trials. Journal of Oncology Practice, 4(4), 162–168. https://doi.org/10.1200/JOP.0842001
4.
BellJ. A. H.BalneavesL. G. (2015). Cancer patient decision making related to clinical trial participation: An integrative review with implications for patients’ relational autonomy. Supportive Care in Cancer, 23(4), 1169–1196. https://doi.org/10.1007/s00520-014-2581-9
BrinkmannS.KvaleS. (2015). Interviews: Learning the craft of qualitative research interviewing (3rd ed.). SAGE Publications Ltd.
7.
BrinkP.WoodM. (1994). Advanced design in nursing research. Sage.
8.
BrownR. F.CadetD. L.HoulihanR. H.ThomsonM. D.PrattE. C.SullivanA.SiminoffL. A. (2013). Perceptions of participation in a phase I, II, or III clinical trial among African American patients with cancer: What do refusers say?Journal of Oncology Practice, 9(6), 287–293. https://doi.org/10.1200/JOP.2013.001039
9.
BrownR. F.ShukE.LeighlN.ButowP.OstroffJ.EdgersonS.TattersallM. (2011). Enhancing decision making about participation in cancer clinical trials: Development of a question prompt list. Supportive Care in Cancer, 19(8), 1227–1238. https://doi.org/10.1007/s00520-010-0942-6
10.
ButowP. N.MacleanM.DunnS. M.TattersallM. H. N.BoyerM. J. (1997). The dynamics of change: Cancer patients’ preferences for information, involvement and support. Annals of Oncology, 8(9), 857–863.
11.
CattS.LangridgeC.FallowfieldL.TalbotD. C.JenkinsV. (2011). Reasons given by patients for participating, or not, in Phase 1 cancer trials. European Journal of Cancer, 47(10), 1490–1497. https://doi.org/10.1016/j.ejca.2011.02.020
12.
ChenC. Y.Rossignac-MilonM.HigginsE. T. (2018). Feeling distressed from making decisions: Assessors’ need to be right. Journal of Personality and Social Psychology, 115(4), 743–761. https://doi.org/10.1037/pspp0000181
13.
ChristofidesE.DobsonJ. A.SolomonM.WatersV.O’DohertyK. C. (2016). Heuristic decision-making about research participation in children with cystic fibrosis. Social Science & Medicine, 162, 32–40. https://doi.org/10.1016/j.socscimed.2016.06.017
14.
ClaymanM. L.GulbrandsenP.MorrisM. A. (2017). A patient in the clinic; A person in the world. Why shared decision making needs to center on the person rather than the medical encounter. Patient Education and Counseling, 100(3), 600–604. Elsevier Ireland Ltd. https://doi.org/10.1016/j.pec.2016.10.016
15.
CohenM. Z.KahnD. L.SteevesR. H. (2000). Hermeneutic phenomenological research: A practical guide for nurse researchers. SAGE Publications Ltd.
16.
DavisonB. J.GleaveM. E.GoldenbergS. L.DegnerL. F.HoffartD.BerkowitzJ. (2002). Assessing information and decision preferences of men with prostate cancer and their partners. Cancer Nursing, 25(1), 42–49. https://doi.org/10.1097/00002820-200202000-00009
17.
DegnerL.SloanJ.VenkateshP. (1997). The control preferences scale. Canadian Journal of Nursing Research Archive, 29(3), 21–43.
18.
DempseyP. A.DempseyA. D. (1996). Nursing research text and workbook. Little/Brown & Co.
19.
DeSantisL.UgarrizaD. N. (2000). The concept of theme as used in qualitative nursing research. Western Journal of Nursing Research, 22(3), 351–372. https://doi.org/10.1177/019394590002200308
20.
DumaN.AguileraJ. V.PaludoJ.HaddoxC. L.VelezM. G.WangY.LeventakosK.HubbardJ. M.MansfieldA. S.GoR. S.AdjeiA. A. (2018). Representation of minorities and women in oncology clinical trials: Review of the past 14 years. Journal of Oncology Practice, 14(1), e1–e10. https://doi.org/10.1200/JOP.2017.025288
21.
EisikovitsZ.KorenC. (2010). Approaches to and outcomes of dyadic interview analysis. Qualitative Health Research, 20(12), 1642–1655. https://doi.org/10.1177/1049732310376520
22.
EvansK. R.LewisM. J.HudsonS. V. (2012). The role of health literacy on African American and Hispanic/Latino perspectives on cancer clinical trials. Journal of Cancer Education, 27(2), 299–305. https://doi.org/10.1007/s13187-011-0300-5
23.
FlorinJ.EhrenbergA.EhnforsM. (2008). Clinical decision-making: Predictors of patient participation in nursing care. Journal of Clinical Nursing, 17(21), 2935–2944. https://doi.org/10.1111/j.1365-2702.2008.02328.x
24.
FouadM. N.LeeJ. Y.CatalanoP. J.VogtT. M.ZafarS. Y.WestD. W.SimonC.KlabundeC. N.KahnK. L.WeeksJ. C.KiefeC. I. (2013). Enrollment of patients with lung and colorectal cancers onto clinical trials. Journal of Oncology Practice, 9(2), Article e40–e47. https://doi.org/10.1200/JOP.2012.000598
25.
GalvinR.ChungC.AchenbachE.DziadkowiecO.SenS. (2020). Barriers to clinical trial enrollment in patients with pancreatic adenocarcinoma eligible for early-phase clinical trials. Oncology, 34(10), 407–412. https://doi.org/10.46883/ONC.2020.3410.0407
26.
GrayTFNolanMTClaymanMLWenzelJA (2019). The decision partner in healthcare decision-making: A concept analysis. International Journal of Nursing Studies, 92, 79–89. https://doi.org/10.1016/j.ijnurstu.2019.01.006
27.
GregersenT. A.BirkelundR.WolderslundM.Netsey‐AfedoM. L.SteffensenK. D.AmmentorpJ. (2019). What matters in clinical trial decision-making: A systematic review of interviews exploring cancer patients’ experiences. Scandinavian Journal of Caring Sciences, 33(2), 266–278. https://doi.org/10.1111/scs.12637
28.
HamelL. M.PennerL. A.AlbrechtT. L.HeathE.GwedeC. K.EgglyS. (2016). Barriers to clinical trial enrollment in racial and ethnic minority patients with cancer. Cancer Control, 23(4), 327–337. https://doi.org/10.1177/107327481602300404
29.
HarikJ. M.HundtN. E.BernardyN. C.NormanS. B.HamblenJ. L. (2016). Desired involvement in treatment decisions among adults with PTSD Symptoms. Journal of Traumatic Stress, 29(3), 221–228. https://doi.org/10.1002/jts
30.
HosieAKochovskaSRiesNGilmoreIParkerDSinclairCSheehanCCollierACaplanGAVisserMXuXLobbESheahanLBrownLLeeWSandersonCRAmgarth-DuffIGreenAEdwardsLAgarMR (2020). Older persons’ and their caregivers’ perspectives and experiences of research participation with impaired decision-making capacity: A scoping review. The Gerontologist, 62(2), Article e112–e122. https://doi.org/10.1093/geront/gnaa118
31.
HuizingaG. A.SleijferD. T.van de WielH. B. M.van der GraafW. T. A. (1999). Decision-making process in patients before entering phase III cancer clinical trials: A pilot study. Cancer Nursing, 22(2), 119–125. https://doi.org/10.1097/00002820-199904000-00003
32.
IannarinoN. T.Palmer-WackerlyA. L. (2021). Fertility preservation decision-making communication between young adult cancer patients and their romantic partners: An application of the DECIDE typology. Health Communication, 3, 1–12. https://doi.org/10.1080/10410236.2020.1868065
33.
JoffeS.CookE. F.ClearyP. D.ClarkJ. W.WeeksJ. C. (2001). Quality of informed consent: A new measure of understanding among research subjects. JNCI Journal of the National Cancer Institute, 93(2), 139–147. https://doi.org/10.4103/0970-258x.262900
34.
KeuschF.RaoR.ChangL.LepkowskiJ.ReddyP.ChoiS. W. (2014). Participation in clinical research: Perspectives of adult patients and parents of pediatric patients undergoing hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 20(10), 1604–1611. https://doi.org/10.1016/j.bbmt.2014.06.020
35.
KriegerJ. L.Krok-SchoenJ. L.DaileyP. M.Palmer-WackerlyA. L.SchoenbergN.PaskettE. D.DignanM. (2017). Distributed cognition in cancer treatment decision making: An application of the DECIDE decision-making styles typology. Qualitative Health Research, 27(8), 1146–1159. https://doi.org/10.1177/1049732316645321
36.
KriegerJ. L.Palmer-WackerlyA.DaileyP. M.Krok-SchoenJ. L.SchoenbergN. E.PaskettE. D. (2015a). Comprehension of randomization and uncertainty in cancer clinical trials decision-making among rural, Appalachian patients. Journal of Cancer Education, 30(4), 743–748. https://doi.org/10.1007/s13187-015-0789-0.Comprehension
37.
KriegerJ. L.Palmer-WackerlyA. L.Krok-SchoenJ. L.DaileyP. M.WojnoJ. C.SchoenbergN.PaskettE. D.DignanM. (2015b). Caregiver perceptions of their influence on cancer treatment decision making: Intersections of language, identity, and illness. Journal of Language and Social Psychology, 34(6), 640–656. https://doi.org/10.1177/0261927X15587556
38.
KunnemanM.Pel-LittelR.BouwmanF. H.GillissenF.SchoonenboomN. S. M.ClausJ. J.van der FlierW. M.SmetsE. M. A. (2017). Patients’ and caregivers’ views on conversations and shared decision making in diagnostic testing for Alzheimer’s disease: The ABIDE project. Alzheimer's & Dementia: Translational Research & Clinical Interventions, 3(3), 314–322. https://doi.org/10.1016/j.trci.2017.04.002
39.
Laidsaar-PowellR.ButowP.BuS.CharlesC.GafniA.FisherA.JuraskovaI. (2016a). Family involvement in cancer treatment decision-making: A qualitative study of patient, family, and clinician attitudes and experiences. Patient Education and Counseling, 99(7), 1146–1155. https://doi.org/10.1016/j.pec.2016.01.014
40.
Laidsaar-PowellR.ButowP.BuS.CharlesC.GafniA.FisherA.JuraskovaI. (2016b). Family involvement in cancer treatment decision-making: A qualitative study of patient, family, and clinician attitudes and experiences. Patient Education and Counseling, 99(7), 1146–1155. https://doi.org/10.1016/j.pec.2016.01.014
41.
Laidsaar-PowellR.ButowP.CharlesC.GafniA.EntwistleV.EpsteinR.JuraskovaI. (2017). The TRIO framework: Conceptual insights into family caregiver involvement and influence throughout cancer treatment decision-making. Patient Education and Counseling, 100(11), 2035–2046. https://doi.org/10.1016/j.pec.2017.05.014
42.
LaraP. N.JrHigdonR.LimN.KwanK.TanakaM.LauD. H. M.WunT.WelbornJ.MeyersF. J.ChristensenS.O’DonnellR.RichmanC.ScudderS. A.TuscanoJ.GandaraD. R.LamK. S. (2001). Prospective evaluation of cancer clinical trial accrual patterns: Identifying potential barriers to enrollment. Journal of Clinical Oncology, 19(6), 1728–1733. https://doi.org/10.1200/jco.2001.19.6.1728
43.
LaryionavaK.PfeilT. A.DietrichM.Reiter-TheilS.HiddemannW.WinklerE. C. (2018). The second patient? Family members of cancer patients and their role in end-of-life decision making. BMC Palliative Care, 17(1), 1–9. https://doi.org/10.1186/s12904-018-0288-2
44.
LeBlancT. W.BloomN.WolfS. P.LowmanS. G.PollakK. I.SteinhauserK. E.ArielyD.TulskyJ. A. (2018). Triadic treatment decision-making in advanced cancer: A pilot study of the roles and perceptions of patients, caregivers, and oncologists. Supportive Care in Cancer, 26(4), 1197–1205. https://doi.org/10.1007/s00520-017-3942-y
45.
LincolnY. S.GubaE. G. (1985). Naturalistic inquiry. SAGE Publications Ltd.
46.
MaxwellJ. (2013). Qualitative research design: An interactive approach (3rd ed.). SAGE Publications Ltd.
47.
MckennaK.CollierJ.HewittM.BlakeH. (2010). Parental involvement in paediatric cancer treatment decisions. European Journal of Cancer Care, 19(5), 621–630. https://doi.org/10.1111/j.1365-2354.2009.01116.x
48.
MorganD. L.AtaieJ.CarderP.HoffmanK. (2013). Introducing dyadic interviews as a method for collecting qualitative data introducing dyadic interviews as a method for collecting qualitative data. Qualitative Health Research, 23(9), 1276–1284. https://doi.org/10.1177/1049732313501889
49.
MorseJ. M. (2015). Critical analysis of strategies for determining rigor in qualitative inquiry. Qualitative Health Research, 25(9), 1212–1222. https://doi.org/10.1177/1049732315588501
50.
MorseJ.FieldP. (1995). Qualitative research methods for health professionals. SAGE Publications Ltd.Second
51.
MurthyV. H.KrumholzH. M.GrossC. P. (2004). Participation in cancer clinical trials. JAMA, 291(22), 2720–2726. https://doi.org/10.14694/EDBK_156686
NippR. D.HongK.PaskettE. D. (2019). Overcoming barriers to clinical trial enrollment. American Society of Clinical Oncology Educational Book, 39(39), 105–114. https://doi.org/10.1200/edbk_243729
54.
NolanM. T.HughesM.NarendraD. P.SoodJ. R.TerryP. B.AstrowA. B.KubJ.ThompsonR. E.SulmasyD. P. (2005). When patients lack capacity: The roles that patients with terminal diagnoses would choose for their physicians and loved ones in making medical decisions. Journal of Pain and Symptom Management, 30(4), 342–353. https://doi.org/10.1016/j.jpainsymman.2005.04.010
55.
O’DonnellM.MonzB.HunskaarS. (2007). General preferences for involvement in treatment decision making among European women with urinary incontinence. Social Science & Medicine, 64(9), 1914–1924. https://doi.org/10.1016/j.socscimed.2007.01.017
56.
Palmer-WackerlyA. L.DaileyP. M.Krok-SchoenJ. L.RhodesN. D.KriegerJ. L. (2018). Patient perceptions of illness identity in cancer clinical trial decision-making. Health Communication, 33(8), 1045–1054. https://doi.org/10.1080/10410236.2017.1331189
57.
PardonK.DeschepperR.SticheleR. V.BernheimJ. L.MortierF.BossuytN.SchallierD.GermonpréP.GaldermansD.Van KerckhovenW.DeliensL. (2010). Preferences of patients with advanced lung cancer regarding the involvement of family and others in medical decision-making. Journal of Palliative Medicine, 13(10), 1199–1203. https://doi.org/10.1089/jpm.2010.0100
PearcyR.WaldronD.O'BoyleC.MacDonaghR. (2008). Proxy assessment of quality of life in patients with prostate cancer: How accurate are partners and urologists?Journal of the Royal Society of Medicine, 101(3), 133–138. https://doi.org/10.1258/jrsm.2008.081002
60.
PoslusznyD. M.BovbjergD. H.AghaM. E.HouJ.-Z.RaptisA.BoyiadzisM. M.Dunbar-JacobJ.SchulzR.DewM. A. (2018). Patient and family caregiver dyadic adherence to the allogeneic hematopoietic cell transplantation medical regimen. Psycho-Oncology, 27(1), 354–358. https://doi.org/10.1002/pon.4393
61.
QuinnG. P.KoskanA.WellsK. J.GonzalezL. E.MeadeC. D.PozoC. L. P.JacobsenP. B. (2012). Cancer Patients’ Fears Related to Clinical Trial Participation: A Qualitative Study. Journal of Cancer Education, 27(2), 257–262. https://doi.org/10.1007/s13187-012-0310-y
62.
RobinsonC. A.BottorffJ. L.PesutB.ZerrJ. (2020). Development and implementation of the Family Caregiver Decision Guide. Qualitative Health Research, 30(2), 303–313. https://doi.org/10.1177/1049732319887166
63.
RoscignoC. I.SavageT. A.KavanaughK.MoroT. T.KilpatrickS. J.StrassnerH. T.GrobmanW. A.KimuraR. E. (2012). Divergent views of hope influencing communications between parents and hospital providers. Qualitative Health Research, 22(9), 1232–1246. https://doi.org/10.1177/1049732312449210
64.
RuttenL. J. F.AroraN. K.BakosA. D.AzizN.RowlandJ. (2005). Information needs and sources of information among cancer patients: A systematic review of research (1980-2003). Patient Education and Counseling, 57(3), 250–261. https://doi.org/10.1016/j.pec.2004.06.006
65.
SchäferC.PutnikK.DietlB.LeiberichP.LoewT. H.KölblO. (2006). Medical decision-making of the patient in the context of the family: Results of a survey. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer, 14(9), 952–959. https://doi.org/10.1007/s00520-006-0025-x
66.
SchapiraM. M.MackenzieE. R.LamR.CasarettD.SeluzickiC. M.BargF. K.MaoJ. J. (2014). Breast cancer survivors willingness to participate in an acupuncture clinical trial: A qualitative study. Supportive Care in Cancer, 22(5), 1207-1215. https://doi.org/10.1007/s00520-013-2073-3
67.
Shannon-DorcyK.DrevdahlD. J. (2011). I had already made up my mind: Patients and caregivers’ perspectives on making the decision to participate in research at a U.S. cancer referral center. Cancer Nursing, 34(6), 428–433. https://doi.org/10.1097/NCC.0b013e318207cb03
68.
SharmaR. K.HughesM. T.NolanM. T.TudorC.KubJ.TerryP. B.SulmasyD. P. (2011). Family understanding of seriously-ill patient preferences for family involvement in healthcare decision making. Journal of General Internal Medicine, 26(8), 881–886. https://doi.org/10.1007/s11606-011-1717-6
69.
ShinD. W.ChoJ.RoterD. L.KimS. Y.SohnS. K.YoonM.-S.KimY.-W.ChoB.ParkJ.-H. (2013). Preferences for and experiences of family involvement in cancer treatment decision-making: Patient-caregiver dyads study. Psycho-Oncology, 22(11), 2624–2631. https://doi.org/10.1002/pon.3339
70.
ShinD. W.ChoJ.RoterD. L.KimS. Y.YangH. K.ParkK.KimH. J.ShinH.-Y.KwonT. G.ParkJ. H. (2017). Attitudes toward family involvement in cancer treatment decision making: The perspectives of patients, family, caregivers, and their oncologists. Psycho-Oncology, 26(6), 770–778. https://doi.org/10.1002/pon.4226
71.
SiminoffL. A. (2013). Incorporating patient and family preferences into evidence-based medicine. BMC Medical Informatics and Decision Making, 13(Suppl 3), S6–S7. https://doi.org/10.1186/1472-6947-13-S3-S6
72.
SinghJ.SloanJ.AthertonP.SmithT.HackT.HuschkaM.RummansT.ClarkM.DiekmannB.DegnerL. (2010). Preferred roles in treatment decision making among patients with cancer: A pooled analysis of studies using the control preferences scale. The American Journal of Managed Care, 16(9), 688–696.
73.
StraussS.Kitt-LewisE. A.AmoryM. (2019). I don’t feel like I have any control of my life at all ... everything overwhelms me. everything”: Analyzing caregiver uncertainty and control through stance marking. Qualitative Health Research, 29(12), 1794–1809. https://doi.org/10.1177/1049732319840283
74.
TalaricoL.ChenG.PazdurR. (2004). Enrollment of elderly patients in clinical trials for cancer drug registration: A 7-year experience by the US food and drug administration. Journal of Clinical Oncology, 22(22), 4626–4631. https://doi.org/10.1200/JCO.2004.02.175
75.
ThorneS.OliffeJ. L.StajduharK. I. (2013). Communicating shared decision-making: Cancer patient perspectives. Patient Education and Counseling, 90(3), 291–296. https://doi.org/10.1016/j.pec.2012.02.018
76.
TruongT. H.WeeksJ. C.CookE. F.JoffeS. (2011). Altruism among participants in cancer clinical trials. Clinical Trials, 8(5), 616–623. https://doi.org/10.1177/1740774511414444
77.
UlrichC. M.KnaflK. A.RatcliffeS. J.RichmondT. S.GradyC.Miller-DavisC.WallenG. R. (2012). Developing a model of the benefits and burdens of research participation in cancer clinical trials. AJOB Primary Research, 3(2), 10–23. https://doi.org/10.1177/0272989x13497264
78.
UmutyanA.ChiechiC.BeckettL. A.PaternitiD. A.TurrellC.GandaraD. R.DavisS. W.WunT.ChenM. S.LaraP. N.Jr (2008). Overcoming barriers to cancer clinical trial accrual: Impact of a mass media campaign. Cancer, 112(1), 212–219. https://doi.org/10.1002/cncr.23170
79.
UngerJ. M.CookE.TaiE.BleyerA. (2016). The role of clinical trial participation in cancer research: Barriers, evidence, and strategies. American Society of Clinical Oncology Educational Book, 36, 185–198. https://doi.org/10.14694/edbk_156686
80.
UngerJ.HershmanD.TillC.MinasianL.OsarogiagbonR.FleuryM.VaidyaR. (2021). When offered to participate”: A systematic review and meta-analysis of patient agreement to participate in cancer clinical trials. JNCI: Journal of the National Cancer Institute, 113(3), 244–257. https://doi.org/10.1093/jnci/djaa155
81.
UngerJ.VaidyaR.HershmanD.MinasianL.FleuryM. (2019). Systematic review and meta-analysis of the magnitude of structural, clinical, and physician and patient barriers to cancer clinical trial participation. JNCI: Journal of the National Cancer Institute, 111(3), 245–255. https://doi.org/10.1093/jnci/djy221
van LentL. G.JabbarianL. J.van GurpJ.HasselaarJ.LolkemaM. P.van WeertJ. C.van der RijtC. C.de JongeM. J. (2021). Identifying patient values impacting the decision whether to participate in early phase clinical cancer trials: A systematic review. Cancer Treatment Reviews, 98, 102217. https://doi.org/10.1016/j.ctrv.2021.102217
84.
WangL.-H.TsaiY.-F.ChenJ.-S.TsayP.-K. (2011). Intention, needs, and expectations of cancer patients participating in clinical trials. Cancer Nursing, 34(2), 117–123.
85.
WenzelJ. A.MbahO.XuJ.Moscou-JacksonG.SaleemH.SakyiK.FordJ. G. (2015). A model of cancer clinical trial decision-making informed by African-American cancer patients. Journal of Racial and Ethnic Health Disparities, 2(2), 192–199. https://doi.org/10.1007/s40615-014-0063-x
86.
WestC. H.DusomeD. L.WinsorJ.RallisonL. B. (2020). Falling down the rabbit Hole: Child and family experiences of pediatric hematopoietic stem cell transplant. Qualitative Health Research, 30(7), 1125–1138. https://doi.org/10.1177/1049732320912410
87.
WilsonA. D.OnwuegbuzieA. J.ManningL. P. (2016). Using paired depth interviews to collect qualitative data. The Qualitative Report, 21(9), 1549–1573. https://doi.org/10.46743/2160-3715/2016.2166
88.
WrayR. J.StrykerJ. E.WinerE.DemetriG.EmmonsK. M. (2007). Do cancer patients fully understand clinical trial participation? A pilot study to assess informed consent and patient expectations. Journal of Cancer Education, 22(1), 21–24. https://doi.org/10.1007/BF03174370
89.
WrightJ. R.WhelanT. J.SchiffS.DuboisS.CrooksD.HainesP. T.DeRosaD.RobertsR. S.GafniA.PritchardK.LevineM. N. (2004). Why cancer patients enter randomized clinical trials: Exploring the factors that influence their decision. Journal of Clinical Oncology, 22(21), 4312–4318. https://doi.org/10.1200/JCO.2004.01.187
90.
YennurajalingamS.RodriguesL. F.ShamiehO. M.TricouC.FilbetM.NaingK.RamaswamyA.Perez-CruzP. E.BautistaM. J. S.BungeS.MuckadenM. A.FakroodenS.SewramV.TejedorA. N.RaoS. S.WilliamsJ. L.LiuD. D.ParkM.LuZ.BrueraE. (2018). Decisional control preferences among patients with advanced cancer: An international multicenter cross-sectional survey. Palliative Medicine, 32(4), 870–880. https://doi.org/10.1177/0269216317747442
91.
ZhangA. Y.SiminoffL. A. (2003). The role of family in treatment decision making by patients with cancer. Oncology Nursing Forum, 30(6), 1022–1028. https://doi.org/10.1188/03.ONF.1022-1028
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
